CIK 0001087294 · Non-accelerated filer<br>Smaller reporting company
CUMBERLAND PHARMACEUTICALS INC
Sign in to watch- Ticker
- CPIX
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- TN
- Entity type
- operating
- EIN
- 621765329
- Phone
- 615-255-0068
- Business address
- 1600 WEST END AVENUE, SUITE 1300, NASHVILLE,, TN, 37203
- 4 Grant or award Director acquired 1,000 shares (grant or award)
- 4 Grant or award Director acquired 1,000 shares (grant or award)
- 4 Shares withheld for taxes Chairman and CEO gave up 25,710 shares (to pay taxes)
- 4 Shares withheld for taxes VP and Chief Compliance Office gave up 1,186 shares (to pay taxes)
- 4 Shares withheld for taxes Vice Pres Sales & Marketing gave up 593 shares (to pay taxes)
- 4 Shares withheld for taxes Vice Pres Organizational Dev gave up 816 shares (to pay taxes)
- 4 Shares withheld for taxes VP Chief Financial Officer gave up 445 shares (to pay taxes)
- ARS Other Annual Report to Security Holders
- 8-K Event Other events
- 424B5 Offering Prospectus
- DEFA14A Proxy Proxy Materials
- DEF 14A Proxy Proxy Statement
- 10-K Report Annual Report
- 8-K Event Results of operations
- SC 13G Stake Amended Statement of Ownership
- 4 Other acquisition Director acquired 1,174 shares (code L)
- 4 Other acquisition Director acquired 1,174 shares (code L)
- 4 Other acquisition Director acquired 6,407 shares (code L)
- 4 Other acquisition Chairman and CEO acquired 1,174 shares (code L)
- EFFECT Other Notice of Effectiveness
Page 9 of 52 · 1,039 filings